TrialX
Image

Dyspnea in Stable Patients With Coronary Artery Disease.

Dyspnea in Stable Patients With Coronary Artery Disease.

Recruiting
100 years and younger
All
Phase N/A

Overview

Single-centre prospective study to characterize causes of dyspnea in stable patients with coronary artery disease and evaluate the possibility to determine the cause of dyspnea before in-depth examination.

Description

Stable patients with dyspnea and coronary artery disease will be included in this single-centre prospective study. In addition to routine clinical examination patients will be interviewed to determine the nature of shortness of breath, angina, presence of chronic heart failure or anxiety using the Medical Research Council Dyspnea scale, the visual analog scale of dyspnea, Borg scale, modified "dictionary" of dyspnea, G. Rose questionnaire, Seattle Angina Questionnaire, Framingham criteria for chronic heart failure and the SHOCK scale. During the subsequent in-depth examination including thyroid hormones, NT-proBNP, hsTroponin, ECG monitoring, six-minute walk test, stress-echo with a diastolic stress test, spirometry and coronary angiography (if necessary) main reason for dyspnea will be established. Possibilities of early (before in-depth examination) determination the reason for dyspnea in stable patients with coronary artery disease will be evaluated.

Eligibility

Inclusion Criteria:

  1. Stable patients with shortness of breath and established diagnosis of coronary artery disease (at least 1 of the following signs):
    • history of myocardial infarction;
    • typical angina without suspected other cause of pain;
    • myocardial ischemia documented by ECG changes during symptoms and/or by results of the stress test;
    • coronary artery stenosis >50% according to coronary angiography.
  2. Signed informed consent.

Exclusion Criteria:

  1. Acute coronary syndrome (myocardial infarction, unstable angina) in the previous month.
  2. Hospitalization with decompensation of CHF in the previous 6 months (including CHF decompensation as the main reason for current hospitalization).
  3. Diseases with an unfavourable prognosis (terminal CKD, CHF NYHA IV, a lung disease with severe respiratory failure).
  4. Contraindications to bicycle stress echocardiography.
  5. Atrial Fibrillation at the time of hospitalization, when the decision not to restore the sinus rhythm.
  6. Mental illnesses and disorders, dementia, drug or alcohol dependence.
  7. Known oncological diseases.

Study details
    Coronary Artery Disease
    Coronary Artery Disease
    Coronary heart disease
    Dyspnea

NCT04408612

National Research Center for Preventive Medicine

5 August 2020

Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.